menu
    • menu

    Company profile for TELA Bio

    NEW Drugs in Dev: 1
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    TELA Bio is a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials that are purposefully designed to address the unmet needs in soft tissue reconstruction. Our seasoned leadership team dedicates their expertise in medical technology to improve outcomes in soft tissue reconstruction procedures and make natural repair solutions more accessible...
    TELA Bio is a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials that are purposefully designed to address the unmet needs in soft tissue reconstruction. Our seasoned leadership team dedicates their expertise in medical technology to improve outcomes in soft tissue reconstruction procedures and make natural repair solutions more accessible to patients. At TELA Bio, we believe that genuine collaboration with surgeons and healthcare providers results in the development of solutions that improve clinical outcomes and empower patient care.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    TELA BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Great Valley Parkway, Suite 24 Malvern, PA 19355
    Telephone
    Telephone
    (484) 320-2930
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.telabio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/tela-bio
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Arvo

    Arvo

    Not Confirmed

    envelop Contact Supplier

    Arvo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    TELA Bio Refreshes Board With Commercial Leaders, Boosts Growth
    TELA Bio Refreshes Board With Commercial Leaders, Boosts Growth

    30 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/30/3285534/0/en/tela-bio-announces-strategic-board-refreshment-with-four-highly-experienced-commerical-leaders-to-accelerate-growth-and-drive-path-to-profitability-the-company-also-reports-prelimi.html

    GLOBENEWSWIRE
    30 Apr 2026
    Share Share
    TELA Bio To Announce First Quarter 2026 Financial Results
    TELA Bio To Announce First Quarter 2026 Financial Results

    21 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/21/3278402/0/en/tela-bio-to-announce-first-quarter-2026-financial-results.html

    GLOBENEWSWIRE
    21 Apr 2026
    Share Share
    TELA Bio Unveils 2025 Q4 And Full-Year Financials
    TELA Bio Unveils 2025 Q4 And Full-Year Financials

    24 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/24/3261734/0/en/TELA-Bio-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    24 Mar 2026
    Share Share
    TELA Bio To Report 2025 Q4 And Full-Year Financials Result
    TELA Bio To Report 2025 Q4 And Full-Year Financials Result

    10 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/10/3253309/0/en/TELA-Bio-to-Announce-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    10 Mar 2026
    Share Share
    TELA Bio Reveals Inducement Grants Per Nasdaq LR 5635(C)(4)
    TELA Bio Reveals Inducement Grants Per Nasdaq LR 5635(C)(4)

    23 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/23/3225062/0/en/TELA-Bio-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    23 Jan 2026
    Share Share
    Tela Bio Sues BD Over Hernia Mesh Monopoly Claims
    Tela Bio Sues BD Over Hernia Mesh Monopoly Claims

    23 Dec 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/medtech/tela-bio-sues-bd-over-hernia-mesh-monopoly-claims

    FIERCE BIOTECH
    23 Dec 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search